Heungkuk Life launches four integrated treatment riders covering diagnosis through rehabilitation

Heungkuk Life Insurance announced Monday that it has launched four integrated treatment riders covering the entire course of care — from diagnosis and treatment through rehabilitation — under a single rider.

The four new riders are an integrated illness treatment rider, an integrated accident treatment rider, a specific circulatory condition integrated treatment rider and an integrated dementia treatment rider.

Previously, customers often had to enroll in separate riders for each stage of care — diagnosis, treatment and rehabilitation. The new integrated riders consolidate the entire treatment process into a single product, making it easier for customers to secure the coverage they need.

Each rider bundles the coverage required for a given condition's treatment journey into one product, allowing customers to receive comprehensive protection across all stages of care without navigating multiple riders.

The integrated accident treatment rider, for example, covers the full course of care following an accident, from initial diagnosis through treatment and rehabilitation. The integrated dementia treatment rider is designed to cover the entire dementia care process, from assessments using the Clinical Dementia Rating scale through treatment and nursing care.

The riders are available through three Heungkuk Life products: Dasarang Integrated Insurance, O-Tuntun 5.10.5 Health Insurance and Dajaedaneung 1540 Insurance.

"As coverage has become more granular, the enrollment process can grow more complex," a Heungkuk Life official said. "We integrated the full treatment process for each condition into a single rider to make it easier for customers to choose. We will continue to improve our product structure from the customer's perspective — reducing complicated enrollment steps and making it simpler to prepare the coverage they need."

Meanwhile, Heungkuk Life is pursuing a strategy of strengthening its third-sector insurance lineup, centered on national health insurance and cancer insurance products, under the new IFRS 17 accounting standards.